Breast Cancer Subtypes and Response to Docetaxel in Node-Positive Breast Cancer: Use of an Immunohistochemical Definition in the BCIRG 001 Trial

PURPOSE: To investigate the prognostic and predictive significance of subtyping node-positive early breast cancer by immunohistochemistry in a clinical trial of a docetaxel-containing regimen. METHODS: Pathologic data from a central laboratory were available for 1,350 patients (91%) from the BCIRG 0...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Hugh, Judith, Hanson, John, Cheang, Maggie Chon U., Nielsen, Torsten O., Perou, Charles M., Dumontet, Charles, Reed, John, Krajewska, Maryla, Treilleux, Isabelle, Rupin, Matthieu, Magherini, Emmanuelle, Mackey, John, Martin, Miguel, Vogel, Charles
Формат: Статья
Язык:English
Опубликовано: American Society of Clinical Oncology 2009
Предметы:
Original Reports
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC2667821/
https://ncbi.nlm.nih.gov/pubmed/19204205
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2008.18.1024
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Internet

https://ncbi.nlm.nih.gov/pmc/articles/PMC2667821/
https://ncbi.nlm.nih.gov/pubmed/19204205
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2008.18.1024

Схожие документы